Switching Children Previously Exposed to Nevirapine to Nevirapine-Based Treatment After Initial Suppression With a Protease-Inhibitor-Based Regimen: Long-Term Follow-Up of a Randomised, Open-Label Trial

The Lancet Infectious Diseases - United Kingdom
doi 10.1016/s1473-3099(12)70051-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Reuse of Nevirapine in Exposed HIV-Infected Children After Protease Inhibitor–Based Viral Suppression

JAMA - Journal of the American Medical Association
Medicine
2010English

HIV-1 Drug Resistance at Antiretroviral Treatment Initiation in Children Previously Exposed to Single-Dose Nevirapine

AIDS
Infectious DiseasesAllergyImmunology
2011English

Is There a Need for Shifting Patients on Long Term Nevirapine Based Regimens to Efavirenz Based Regimens: A Cross-Sectional Study?

Drug discoveries & therapeutics
MedicineToxicologyPharmaceuticsPharmacology
2018English

Long-Term Follow Up of Workers Exposed to Solvents.

Occupational and Environmental Medicine
EnvironmentalPublic HealthOccupational Health
1990English

Long-Term Follow-Up After Callosotomy-A Prospective, Population Based, Observational Study

Epilepsia
Neurology
2013English

Long-Term Follow-Up in an Open-Label Trial of Triheptanoin in GLUT1 Deficiency Syndrome: A Sustained Dramatic Effect

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2019English

Long-Term Safety, Efficacy, and Quality of Life Outcomes With Adjunctive Brivaracetam Treatment at Individualized Doses in Patients With Epilepsy: An Up to 11-Year, Open-Label, Follow-Up Trial

Epilepsia
Neurology
2020English

Long-Term Benefits of Nevirapine-Containing Regimens: Multicenter Study With 506 Patients, Followed-Up a Median of 9 Years

Current HIV Research
VirologyInfectious Diseases
2012English

Response to Antiretroviral Therapy After a Single, Peripartum Dose of Nevirapine

New England Journal of Medicine
Medicine
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy